Navigation Links
Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients

SALT LAKE CITY, June 04, 2007 /PRNewswire-FirstCall/ -- BSD Medical Corp. announced today that the results of a 340 patient randomized Phase III clinical trial testing the benefit of adding hyperthermia therapy to chemotherapy were presented at the annual American Society of Clinical Oncology (ASCO) conference underway in Chicago, Illinois. According to the results of this clinical study, which was conducted at nine major European cancer treatment institutions and at Duke University Medical Center in the USA, both disease-free survival time and local progression free survival time for patients with locally advanced, high-grade soft tissue sarcomas nearly doubled when hyperthermia therapy was added to chemotherapy, as compared to patients who received chemotherapy alone.

The patients enrolled in this clinical study were very ill, with high-grade (II/III) soft tissue sarcomas and were at significant risk of local failure and metastasis. The patients were randomly assigned to receive either chemotherapy alone or chemotherapy combined with hyperthermia therapy. The patient characteristics were well balanced between these two groups. Their treatments were administered in 4 cycles every 3 weeks before and after surgery and radiation therapy. For patients who received both hyperthermia therapy and chemotherapy the median disease free survival was 31.7 months, compared to 16.2 months for those who received chemotherapy alone (p=0.004), a 95% increase. The median local progression free survival rate was estimated at 45.3 months for patients who received chemotherapy plus hyperthermia therapy, compared to 23.7 months for patients who received chemotherapy alone (p=0.01), a 91% increase.

The study was conducted under the direction of the European Society of Hyperthermic Oncology (ESHO RHT-95) and the European Organization for Research and Treatment of Cancer (EORTC 62961). Rolf Issels, MD PhD of the Munich U
'"/>




Page: 1 2 3

Related medicine technology :

1. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
2. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
3. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
4. New Data Show Pfizers Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
5. Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New Treatment Benchmark in Patients With Metastatic Colorectal Cancer
6. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
7. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
8. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
9. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
10. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
11. Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting

Post Your Comments:
(Date:11/25/2009)...re/ -- Reportlinker.com announces that a new marke..., United States Dental Devices Market Analysis...nker.com/p0158733/United-States-Dental-Devices-Mar...ted States Dental Devices Market Analysis and Fore... an essential source for in-depth information and ...
(Date:11/25/2009)...Newswire/ -- According to Millennium Research Grou...y market intelligence, the nearly $3 billion US ma...see rapid growth over the next five years despite ...r Trauma Devices 2010 report finds that this ma... years, with competitors introducing specialized d...
(Date:11/25/2009)...re/ -- Reportlinker.com announces that a new marke..., Intranasal Drug Delivery - US Market Trends ...267/Intranasal-Drug-Delivery---US-Market-Trends--A...y market is witnessing an expansion of therapeutic...cal therapeutic drugs to the delivery of systemic ...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Bruce E Katz M D of Juva Skin 26amp 3B Laser Center Pioneers 26quot 3BThe Madonna Lift 26quot 3B Fractional Eyelift Procedure 58112 1Bruce E Katz M D of Juva Skin 26amp 3B Laser Center Pioneers 26quot 3BThe Madonna Lift 26quot 3B Fractional Eyelift Procedure 58112 2Webinar Series Launches for Eye Care Personnel 58108 1Webinar Series Launches for Eye Care Personnel 58108 2Webinar Series Launches for Eye Care Personnel 58108 3Webinar Series Launches for Eye Care Personnel 58108 4CASA Report Finds Teens Who Have Infrequent Family Dinners Likelier to Drink Smoke Use Marijuana 58104 1CASA Report Finds Teens Who Have Infrequent Family Dinners Likelier to Drink Smoke Use Marijuana 58104 2CASA Report Finds Teens Who Have Infrequent Family Dinners Likelier to Drink Smoke Use Marijuana 58104 3CASA Report Finds Teens Who Have Infrequent Family Dinners Likelier to Drink Smoke Use Marijuana 58104 4CASA Report Finds Teens Who Have Infrequent Family Dinners Likelier to Drink Smoke Use Marijuana 58104 5
...-FirstCall/ Haemacure,Corporation , a Montreal-bas...ced the preliminary findings of the content analys...ndings confirm the presence of a number of,protein...ldwide,markets, including albumin, plasminogen, im...strategic significance for Haemacure as,revenues e...
... 2007 - Next Safety,Inc. has identified basic sci...ulmonary drug delivery. This proprietary technolog...ions deep into the,pulmonary system. It is conside...e it rapidly administers aerosolized drugs to the,...iencies. The,delivery technique has multiple appli...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Next Safety, Inc.'s Innovative Drug Delivery System Will Replace,Cigarettes and Significantly Advance Pulmonary Medication Delivery 2
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its ...mic data. It shows that the lethality of the viru...ng the virus,s current outbreak in the spring of 2...0 (s.d. 0.1). The H1N1 infectivity count, however,...ton (PRWEB) November 27, 2009 -- Biotech firm Repl...
(Date:11/27/2009)...AMIR, Israel, Nov. 27 Sh...mir" ), a leading provider of innovative products ...unced today that its board of directors had declar...of US$ 10 million (approximately NIS 37.62 million...e of exchange), or approximately US$ 0.609 (approx...
(Date:11/27/2009)... Voyant Health™ announced today that Spe... its TraumaCad Enterprise orthopedic templating so... , (PRWEB) November 27, 2...pectrum Health (Grand Rapids, Michigan) has licens...solution and its TraumaCad Extend workflow solutio...
(Date:11/26/2009)...ON, N.J., Nov. 27 The diabetes pop...er the next 25 years and annual medical spending o... from $113 billion today, according to a study pub...The National Changing Diabetes ® Program (NC...nalysis by a team from the University of Chicago. ...
(Date:11/26/2009)... No more letters from the North Pole, Textsant...essages from Santa , Nort...rational efficiencies at the North Pole Santa Clau...en all over the globe informed of his Christmas pr...;s research department have identified a large and...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...t yesterday with the office of Minister for Ageing...Ps attending aged care facilities, //as set out in... The current structure of the Medicare Benefits ..., said today the number of general practitioners a...
...ada has warned women strongly about the side effec...'. Evra can trigger off //the development of sever...ches which contains ethinyl estradiol is available...g blood clots. Use of oral birth control pills co...
...s in the Department of Obstetrics, Gynecology & Re... The Albert Einstein //College of Medicine report ...ced reduced genital sensation and were more likely.... With the help of non-invasive techniques, they s...
..., Flu killed about 12,000 people last winter and t... to a shortage in vaccines.// This year due ...ccine millions of elderly and vulnerable patients ...ar. Researchers warn that those who do not get vac...
... gamble at least five times a year have more healt... a new study reveals.// And people with a se...ort serious health problems, such as increased hea...red is whether gambling is associated with health ...
...ch published in the November edition of the journa... 7 to 11 in Augusta, Georgia. A quarter of the kid...oblems, reported the online edition of the health ..., basketball, soccer or jump rope - every day for ...
Other Medicine News:Health News:Competitive women cyclists experience reduced genital sensation 2Health News:Flu Vaccine Shortage In Britain Causes Anxiety 2Health News:Odds Are That Gamblers Have More Health Problems 2
... system is designed for very fast and clear separa... This System allows the user to cast, run, and per.... Complete system with : 1 x electrophoresis tank ... (105 x 83 mm tray), 2 x MT-T02 (50 x 60 mm tray),...
... centimeter ruler etched into the gel tray which c... connecting cables, three 7x10 cm gel trays, 4 alu... combs. The Chameleon can accomodate up to five co... a maximum of 120 samples with a 2.5 cm path lengt...
...sts of a Separation-Control unit for system contro...gel staining. The optional PhastTransfer Kit quick...it. Electrophoresis is performed on a thermostatic...ely from 0 to +70 C. Multi-step programming capabi...
...nd ready-to-use gels are the key components of Elc...merged gel electrophoresis. We provide other compo...tibility and optimal performance, at a reasonable ...ng tray, the system includes a power supply, a con...
Medicine Products: